APO Research
Talk to an analyst

APO RESEARCH · REPORT

NAD+ IV Therapy

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global NAD+ IV Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025194 pages

Choose your research edition.

Industry ResearchNAD+ IV Therapy Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal NAD+ IV Therapy Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal NAD+ IV Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NAD+ IV Therapy Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal NAD+ IV Therapy Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global NAD+ IV Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for NAD+ IV Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for NAD+ IV Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NAD+ IV Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for NAD+ IV Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of NAD+ IV Therapy include Toronto Functional Medicine Centre, Thedripclub, The Wellness Lab, Seaside Skin Care, Rocky Mountain Ivmedics, Reset IV, Premiumhealth, Nadclinic and Mobileivmedics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global NAD+ IV Therapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NAD+ IV Therapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NAD+ IV Therapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the NAD+ IV Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

NAD+ IV Therapy Segment by Company

Toronto Functional Medicine Centre

Thedripclub

The Wellness Lab

Seaside Skin Care

Rocky Mountain Ivmedics

Reset IV

Premiumhealth

Nadclinic

Mobileivmedics

LIVV Natural

IV Boost UK

Hydrate IV Bar

Effect Doctors

Conciergemdla

BioReset Medical

Azivmedics

NAD+ IV Therapy Segment by Type

NAD+ Mixed Vitamin Injections

Pure NAD+ Injection

NAD+ IV Therapy Segment by Application

Clinic

Hospital

Residential

NAD+ IV Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NAD+ IV Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NAD+ IV Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NAD+ IV Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of NAD+ IV Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global NAD+ IV Therapy industry.

Chapter 3: Detailed analysis of NAD+ IV Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NAD+ IV Therapyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global NAD+ IV Therapy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of NAD+ Mixed Vitamin Injections Table 3. Key Players of Pure NAD+ Injection Table 4. Global NAD+ IV Therapy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Clinic Table 6. Key Players of Hospital Table 7. Key Players of Residential Table 8. Global NAD+ IV Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global NAD+ IV Therapy Market Size by Region (2021-2026) & (US$ Million) Table 10. Global NAD+ IV Therapy Market Share by Region (2021-2026) Table 11. Global NAD+ IV Therapy Market Size by Region (2027-2032) & (US$ Million) Table 12. Global NAD+ IV Therapy Market Share by Region (2027-2032) Table 13. NAD+ IV Therapy Industry Trends Table 14. NAD+ IV Therapy Industry Drivers Table 15. NAD+ IV Therapy Industry Opportunities and Challenges Table 16. NAD+ IV Therapy Industry Restraints Table 17. Global NAD+ IV Therapy Revenue by Company (US$ Million) & (2021-2026) Table 18. Global NAD+ IV Therapy Revenue Market Share by Company (2021-2026) Table 19. Global NAD+ IV Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global NAD+ IV Therapy Key Company Head Office and Area Served Table 21. Global NAD+ IV Therapy Company, Product Type & Application Table 22. Global NAD+ IV Therapy Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global NAD+ IV Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global NAD+ IV Therapy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global NAD+ IV Therapy Market Size by Type (2021-2026) & (US$ Million) Table 27. Global NAD+ IV Therapy Market Size by Type (2027-2032) & (US$ Million) Table 28. Global NAD+ IV Therapy Revenue Market Share by Type (2021-2026) Table 29. Global NAD+ IV Therapy Revenue Market Share by Type (2027-2032) Table 30. Global NAD+ IV Therapy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global NAD+ IV Therapy Market Size by Application (2021-2026) & (US$ Million) Table 32. Global NAD+ IV Therapy Market Size by Application (2027-2032) & (US$ Million) Table 33. Global NAD+ IV Therapy Revenue Market Share by Application (2021-2026) Table 34. Global NAD+ IV Therapy Revenue Market Share by Application (2027-2032) Table 35. Toronto Functional Medicine Centre Company Information Table 36. Toronto Functional Medicine Centre Business Overview Table 37. Toronto Functional Medicine Centre NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Toronto Functional Medicine Centre NAD+ IV Therapy Product Portfolio Table 39. Toronto Functional Medicine Centre Recent Development Table 40. Thedripclub Company Information Table 41. Thedripclub Business Overview Table 42. Thedripclub NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Thedripclub NAD+ IV Therapy Product Portfolio Table 44. Thedripclub Recent Development Table 45. The Wellness Lab Company Information Table 46. The Wellness Lab Business Overview Table 47. The Wellness Lab NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. The Wellness Lab NAD+ IV Therapy Product Portfolio Table 49. The Wellness Lab Recent Development Table 50. Seaside Skin Care Company Information Table 51. Seaside Skin Care Business Overview Table 52. Seaside Skin Care NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Seaside Skin Care NAD+ IV Therapy Product Portfolio Table 54. Seaside Skin Care Recent Development Table 55. Rocky Mountain Ivmedics Company Information Table 56. Rocky Mountain Ivmedics Business Overview Table 57. Rocky Mountain Ivmedics NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Rocky Mountain Ivmedics NAD+ IV Therapy Product Portfolio Table 59. Rocky Mountain Ivmedics Recent Development Table 60. Reset IV Company Information Table 61. Reset IV Business Overview Table 62. Reset IV NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Reset IV NAD+ IV Therapy Product Portfolio Table 64. Reset IV Recent Development Table 65. Premiumhealth Company Information Table 66. Premiumhealth Business Overview Table 67. Premiumhealth NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Premiumhealth NAD+ IV Therapy Product Portfolio Table 69. Premiumhealth Recent Development Table 70. Nadclinic Company Information Table 71. Nadclinic Business Overview Table 72. Nadclinic NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Nadclinic NAD+ IV Therapy Product Portfolio Table 74. Nadclinic Recent Development Table 75. Mobileivmedics Company Information Table 76. Mobileivmedics Business Overview Table 77. Mobileivmedics NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Mobileivmedics NAD+ IV Therapy Product Portfolio Table 79. Mobileivmedics Recent Development Table 80. LIVV Natural Company Information Table 81. LIVV Natural Business Overview Table 82. LIVV Natural NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. LIVV Natural NAD+ IV Therapy Product Portfolio Table 84. LIVV Natural Recent Development Table 85. IV Boost UK Company Information Table 86. IV Boost UK Business Overview Table 87. IV Boost UK NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. IV Boost UK NAD+ IV Therapy Product Portfolio Table 89. IV Boost UK Recent Development Table 90. Hydrate IV Bar Company Information Table 91. Hydrate IV Bar Business Overview Table 92. Hydrate IV Bar NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Hydrate IV Bar NAD+ IV Therapy Product Portfolio Table 94. Hydrate IV Bar Recent Development Table 95. Effect Doctors Company Information Table 96. Effect Doctors Business Overview Table 97. Effect Doctors NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Effect Doctors NAD+ IV Therapy Product Portfolio Table 99. Effect Doctors Recent Development Table 100. Conciergemdla Company Information Table 101. Conciergemdla Business Overview Table 102. Conciergemdla NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Conciergemdla NAD+ IV Therapy Product Portfolio Table 104. Conciergemdla Recent Development Table 105. BioReset Medical Company Information Table 106. BioReset Medical Business Overview Table 107. BioReset Medical NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. BioReset Medical NAD+ IV Therapy Product Portfolio Table 109. BioReset Medical Recent Development Table 110. Azivmedics Company Information Table 111. Azivmedics Business Overview Table 112. Azivmedics NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Azivmedics NAD+ IV Therapy Product Portfolio Table 114. Azivmedics Recent Development Table 115. North America NAD+ IV Therapy Market Size by Type (2021-2026) & (US$ Million) Table 116. North America NAD+ IV Therapy Market Size by Type (2027-2032) & (US$ Million) Table 117. North America NAD+ IV Therapy Market Size by Application (2021-2026) & (US$ Million) Table 118. North America NAD+ IV Therapy Market Size by Application (2027-2032) & (US$ Million) Table 119. North America NAD+ IV Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America NAD+ IV Therapy Market Size by Country (2021-2026) Table 121. North America NAD+ IV Therapy Market Size by Country (2027-2032) Table 122. Europe NAD+ IV Therapy Market Size by Type (2021-2026) & (US$ Million) Table 123. Europe NAD+ IV Therapy Market Size by Type (2027-2032) & (US$ Million) Table 124. Europe NAD+ IV Therapy Market Size by Application (2021-2026) & (US$ Million) Table 125. Europe NAD+ IV Therapy Market Size by Application (2027-2032) & (US$ Million) Table 126. Europe NAD+ IV Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe NAD+ IV Therapy Market Size by Country (2021-2026) Table 128. Europe NAD+ IV Therapy Market Size by Country (2027-2032) Table 129. China NAD+ IV Therapy Market Size by Type (2021-2026) & (US$ Million) Table 130. China NAD+ IV Therapy Market Size by Type (2027-2032) & (US$ Million) Table 131. China NAD+ IV Therapy Market Size by Application (2021-2026) & (US$ Million) Table 132. China NAD+ IV Therapy Market Size by Application (2027-2032) & (US$ Million) Table 133. Asia NAD+ IV Therapy Market Size by Type (2021-2026) & (US$ Million) Table 134. Asia NAD+ IV Therapy Market Size by Type (2027-2032) & (US$ Million) Table 135. Asia NAD+ IV Therapy Market Size by Application (2021-2026) & (US$ Million) Table 136. Asia NAD+ IV Therapy Market Size by Application (2027-2032) & (US$ Million) Table 137. Asia NAD+ IV Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Asia NAD+ IV Therapy Market Size by Country (2021-2026) Table 139. Asia NAD+ IV Therapy Market Size by Country (2027-2032) Table 140. South America, Middle East & Africa NAD+ IV Therapy Market Size by Type (2021-2026) & (US$ Million) Table 141. South America, Middle East & Africa NAD+ IV Therapy Market Size by Type (2027-2032) & (US$ Million) Table 142. South America, Middle East & Africa NAD+ IV Therapy Market Size by Application (2021-2026) & (US$ Million) Table 143. South America, Middle East & Africa NAD+ IV Therapy Market Size by Application (2027-2032) & (US$ Million) Table 144. South America, Middle East & Africa NAD+ IV Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. South America, Middle East & Africa NAD+ IV Therapy Market Size by Country (2021-2026) Table 146. South America, Middle East & Africa NAD+ IV Therapy Market Size by Country (2027-2032) Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. NAD+ IV Therapy Product Image Figure 2. Global NAD+ IV Therapy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global NAD+ IV Therapy Market Share by Type: 2025 VS 2032 Figure 4. NAD+ Mixed Vitamin Injections Image Figure 5. Pure NAD+ Injection Image Figure 6. Global NAD+ IV Therapy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global NAD+ IV Therapy Market Share by Application: 2025 VS 2032 Figure 8. Clinic Image Figure 9. Hospital Image Figure 10. Residential Image Figure 11. Global NAD+ IV Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 13. Global NAD+ IV Therapy Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global NAD+ IV Therapy Market Share by Players in 2025 Figure 16. Global Top 5 and 10 NAD+ IV Therapy Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global NAD+ IV Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global NAD+ IV Therapy Revenue Market Share by Type (2021-2032) Figure 20. Global NAD+ IV Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global NAD+ IV Therapy Revenue Market Share by Application (2021-2032) Figure 22. North America NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 23. North America NAD+ IV Therapy Market Share by Type (2021-2032) Figure 24. North America NAD+ IV Therapy Market Share by Application (2021-2032) Figure 25. North America NAD+ IV Therapy Market Share by Country (2021-2032) Figure 26. United States NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 27. Canada NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 28. Mexico NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 29. Europe NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 30. Europe NAD+ IV Therapy Market Share by Type (2021-2032) Figure 31. Europe NAD+ IV Therapy Market Share by Application (2021-2032) Figure 32. Europe NAD+ IV Therapy Market Share by Country (2021-2032) Figure 33. Germany NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 34. France NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 35. U.K. NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 36. Italy NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 37. Russia NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 39. China NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 40. China NAD+ IV Therapy Market Share by Type (2021-2032) Figure 41. China NAD+ IV Therapy Market Share by Application (2021-2032) Figure 42. Asia NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 43. Asia NAD+ IV Therapy Market Share by Type (2021-2032) Figure 44. Asia NAD+ IV Therapy Market Share by Application (2021-2032) Figure 45. Asia NAD+ IV Therapy Market Share by Country (2021-2032) Figure 46. Japan NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 47. South Korea NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 50. India NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 51. Australia NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa NAD+ IV Therapy Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa NAD+ IV Therapy Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa NAD+ IV Therapy Market Share by Country (2021-2032) Figure 56. Brazil NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 57. South Africa NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 59. Turkey NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 60. Argentina NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 61. UAE NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 62. Egypt NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 63. Chile NAD+ IV Therapy Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • NAD+ Mixed Vitamin Injections
  • Pure NAD+ Injection
Applications
  • Clinic
  • Hospital
  • Residential
Companies covered
  • Toronto Functional Medicine Centre
  • Thedripclub
  • The Wellness Lab
  • Seaside Skin Care
  • Rocky Mountain Ivmedics
  • Reset IV
  • Premiumhealth
  • Nadclinic
  • Mobileivmedics
  • LIVV Natural
  • IV Boost UK
  • Hydrate IV Bar
  • Effect Doctors
  • Conciergemdla
  • BioReset Medical
  • Azivmedics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global NAD+ IV Therapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 NAD+ Mixed Vitamin Injections
  5. 1.2.3 Pure NAD+ Injection
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global NAD+ IV Therapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Clinic
  9. 1.3.3 Hospital
  10. 1.3.4 Residential
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global NAD+ IV Therapy Growth Trends by Region
  13. 1.5.1 Global NAD+ IV Therapy Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 NAD+ IV Therapy Market Size by Region (2021-2026)
  15. 1.5.3 NAD+ IV Therapy Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global NAD+ IV Therapy Market Dynamics
  1. 2.1 NAD+ IV Therapy Industry Trends
  2. 2.2 NAD+ IV Therapy Industry Drivers
  3. 2.3 NAD+ IV Therapy Industry Opportunities and Challenges
  4. 2.4 NAD+ IV Therapy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global NAD+ IV Therapy Revenue by Company (2021-2026)
  2. 3.2 Global NAD+ IV Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global NAD+ IV Therapy Key Company Head office and Area Served
  4. 3.4 Global NAD+ IV Therapy Company, Product Type & Application
  5. 3.5 Global NAD+ IV Therapy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global NAD+ IV Therapy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 NAD+ IV Therapy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 NAD+ IV Therapy Tier 1, Tier 2, and Tier 3
4 NAD+ IV Therapy Market by Type
  1. 4.1 Global NAD+ IV Therapy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global NAD+ IV Therapy Market Size by Type (2021-2032)
  3. 4.3 Global NAD+ IV Therapy Market Size Share by Type (2021-2032)
5 NAD+ IV Therapy Market by Application
  1. 5.1 Global NAD+ IV Therapy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global NAD+ IV Therapy Market Size by Application (2021-2032)
  3. 5.3 Global NAD+ IV Therapy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Toronto Functional Medicine Centre
  2. 6.1.1 Toronto Functional Medicine Centre Company Information
  3. 6.1.2 Toronto Functional Medicine Centre Business Overview
  4. 6.1.3 Toronto Functional Medicine Centre NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Toronto Functional Medicine Centre NAD+ IV Therapy Product Portfolio
  6. 6.1.5 Toronto Functional Medicine Centre Recent Developments
  7. 6.2 Thedripclub
  8. 6.2.1 Thedripclub Company Information
  9. 6.2.2 Thedripclub Business Overview
  10. 6.2.3 Thedripclub NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Thedripclub NAD+ IV Therapy Product Portfolio
  12. 6.2.5 Thedripclub Recent Developments
  13. 6.3 The Wellness Lab
  14. 6.3.1 The Wellness Lab Company Information
  15. 6.3.2 The Wellness Lab Business Overview
  16. 6.3.3 The Wellness Lab NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 The Wellness Lab NAD+ IV Therapy Product Portfolio
  18. 6.3.5 The Wellness Lab Recent Developments
  19. 6.4 Seaside Skin Care
  20. 6.4.1 Seaside Skin Care Company Information
  21. 6.4.2 Seaside Skin Care Business Overview
  22. 6.4.3 Seaside Skin Care NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Seaside Skin Care NAD+ IV Therapy Product Portfolio
  24. 6.4.5 Seaside Skin Care Recent Developments
  25. 6.5 Rocky Mountain Ivmedics
  26. 6.5.1 Rocky Mountain Ivmedics Company Information
  27. 6.5.2 Rocky Mountain Ivmedics Business Overview
  28. 6.5.3 Rocky Mountain Ivmedics NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Rocky Mountain Ivmedics NAD+ IV Therapy Product Portfolio
  30. 6.5.5 Rocky Mountain Ivmedics Recent Developments
  31. 6.6 Reset IV
  32. 6.6.1 Reset IV Company Information
  33. 6.6.2 Reset IV Business Overview
  34. 6.6.3 Reset IV NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Reset IV NAD+ IV Therapy Product Portfolio
  36. 6.6.5 Reset IV Recent Developments
  37. 6.7 Premiumhealth
  38. 6.7.1 Premiumhealth Company Information
  39. 6.7.2 Premiumhealth Business Overview
  40. 6.7.3 Premiumhealth NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Premiumhealth NAD+ IV Therapy Product Portfolio
  42. 6.7.5 Premiumhealth Recent Developments
  43. 6.8 Nadclinic
  44. 6.8.1 Nadclinic Company Information
  45. 6.8.2 Nadclinic Business Overview
  46. 6.8.3 Nadclinic NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Nadclinic NAD+ IV Therapy Product Portfolio
  48. 6.8.5 Nadclinic Recent Developments
  49. 6.9 Mobileivmedics
  50. 6.9.1 Mobileivmedics Company Information
  51. 6.9.2 Mobileivmedics Business Overview
  52. 6.9.3 Mobileivmedics NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Mobileivmedics NAD+ IV Therapy Product Portfolio
  54. 6.9.5 Mobileivmedics Recent Developments
  55. 6.10 LIVV Natural
  56. 6.10.1 LIVV Natural Company Information
  57. 6.10.2 LIVV Natural Business Overview
  58. 6.10.3 LIVV Natural NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 LIVV Natural NAD+ IV Therapy Product Portfolio
  60. 6.10.5 LIVV Natural Recent Developments
  61. 6.11 IV Boost UK
  62. 6.11.1 IV Boost UK Company Information
  63. 6.11.2 IV Boost UK Business Overview
  64. 6.11.3 IV Boost UK NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 IV Boost UK NAD+ IV Therapy Product Portfolio
  66. 6.11.5 IV Boost UK Recent Developments
  67. 6.12 Hydrate IV Bar
  68. 6.12.1 Hydrate IV Bar Company Information
  69. 6.12.2 Hydrate IV Bar Business Overview
  70. 6.12.3 Hydrate IV Bar NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Hydrate IV Bar NAD+ IV Therapy Product Portfolio
  72. 6.12.5 Hydrate IV Bar Recent Developments
  73. 6.13 Effect Doctors
  74. 6.13.1 Effect Doctors Company Information
  75. 6.13.2 Effect Doctors Business Overview
  76. 6.13.3 Effect Doctors NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Effect Doctors NAD+ IV Therapy Product Portfolio
  78. 6.13.5 Effect Doctors Recent Developments
  79. 6.14 Conciergemdla
  80. 6.14.1 Conciergemdla Company Information
  81. 6.14.2 Conciergemdla Business Overview
  82. 6.14.3 Conciergemdla NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Conciergemdla NAD+ IV Therapy Product Portfolio
  84. 6.14.5 Conciergemdla Recent Developments
  85. 6.15 BioReset Medical
  86. 6.15.1 BioReset Medical Company Information
  87. 6.15.2 BioReset Medical Business Overview
  88. 6.15.3 BioReset Medical NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 BioReset Medical NAD+ IV Therapy Product Portfolio
  90. 6.15.5 BioReset Medical Recent Developments
  91. 6.16 Azivmedics
  92. 6.16.1 Azivmedics Company Information
  93. 6.16.2 Azivmedics Business Overview
  94. 6.16.3 Azivmedics NAD+ IV Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Azivmedics NAD+ IV Therapy Product Portfolio
  96. 6.16.5 Azivmedics Recent Developments
7 North America
  1. 7.1 North America NAD+ IV Therapy Market Size (2021-2032)
  2. 7.2 North America NAD+ IV Therapy Market Size by Type
  3. 7.2.1 North America NAD+ IV Therapy Market Size by Type (2021-2026)
  4. 7.2.2 North America NAD+ IV Therapy Market Size by Type (2027-2032)
  5. 7.2.3 North America NAD+ IV Therapy Market Share by Type (2021-2032)
  6. 7.3 North America NAD+ IV Therapy Market Size by Application
  7. 7.3.1 North America NAD+ IV Therapy Market Size by Application (2021-2026)
  8. 7.3.2 North America NAD+ IV Therapy Market Size by Application (2027-2032)
  9. 7.3.3 North America NAD+ IV Therapy Market Share by Application (2021-2032)
  10. 7.4 North America NAD+ IV Therapy Market Size by Country
  11. 7.4.1 North America NAD+ IV Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America NAD+ IV Therapy Market Size by Country (2021-2026)
  13. 7.4.3 North America NAD+ IV Therapy Market Size by Country (2027-2032)
  14. 7.4.4 North America NAD+ IV Therapy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe NAD+ IV Therapy Market Size (2021-2032)
  2. 8.2 Europe NAD+ IV Therapy Market Size by Type
  3. 8.2.1 Europe NAD+ IV Therapy Market Size by Type (2021-2026)
  4. 8.2.2 Europe NAD+ IV Therapy Market Size by Type (2027-2032)
  5. 8.2.3 Europe NAD+ IV Therapy Market Share by Type (2021-2032)
  6. 8.3 Europe NAD+ IV Therapy Market Size by Application
  7. 8.3.1 Europe NAD+ IV Therapy Market Size by Application (2021-2026)
  8. 8.3.2 Europe NAD+ IV Therapy Market Size by Application (2027-2032)
  9. 8.3.3 Europe NAD+ IV Therapy Market Share by Application (2021-2032)
  10. 8.4 Europe NAD+ IV Therapy Market Size by Country
  11. 8.4.1 Europe NAD+ IV Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe NAD+ IV Therapy Market Size by Country (2021-2026)
  13. 8.4.3 Europe NAD+ IV Therapy Market Size by Country (2027-2032)
  14. 8.4.4 Europe NAD+ IV Therapy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China NAD+ IV Therapy Market Size (2021-2032)
  2. 9.2 China NAD+ IV Therapy Market Size by Type
  3. 9.2.1 China NAD+ IV Therapy Market Size by Type (2021-2026)
  4. 9.2.2 China NAD+ IV Therapy Market Size by Type (2027-2032)
  5. 9.2.3 China NAD+ IV Therapy Market Share by Type (2021-2032)
  6. 9.3 China NAD+ IV Therapy Market Size by Application
  7. 9.3.1 China NAD+ IV Therapy Market Size by Application (2021-2026)
  8. 9.3.2 China NAD+ IV Therapy Market Size by Application (2027-2032)
  9. 9.3.3 China NAD+ IV Therapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia NAD+ IV Therapy Market Size (2021-2032)
  2. 10.2 Asia NAD+ IV Therapy Market Size by Type
  3. 10.2.1 Asia NAD+ IV Therapy Market Size by Type (2021-2026)
  4. 10.2.2 Asia NAD+ IV Therapy Market Size by Type (2027-2032)
  5. 10.2.3 Asia NAD+ IV Therapy Market Share by Type (2021-2032)
  6. 10.3 Asia NAD+ IV Therapy Market Size by Application
  7. 10.3.1 Asia NAD+ IV Therapy Market Size by Application (2021-2026)
  8. 10.3.2 Asia NAD+ IV Therapy Market Size by Application (2027-2032)
  9. 10.3.3 Asia NAD+ IV Therapy Market Share by Application (2021-2032)
  10. 10.4 Asia NAD+ IV Therapy Market Size by Country
  11. 10.4.1 Asia NAD+ IV Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia NAD+ IV Therapy Market Size by Country (2021-2026)
  13. 10.4.3 Asia NAD+ IV Therapy Market Size by Country (2027-2032)
  14. 10.4.4 Asia NAD+ IV Therapy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa NAD+ IV Therapy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa NAD+ IV Therapy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa NAD+ IV Therapy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa NAD+ IV Therapy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa NAD+ IV Therapy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa NAD+ IV Therapy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa NAD+ IV Therapy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa NAD+ IV Therapy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa NAD+ IV Therapy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa NAD+ IV Therapy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa NAD+ IV Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa NAD+ IV Therapy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa NAD+ IV Therapy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa NAD+ IV Therapy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst